Catalyst Wire Dossier Catalyst Wire Dossier

MICARDIS HCT

Telmisartan and hydrochlorothiazide · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for MICARDIS HCT, covering 2007-02-27 to 2022-12-19. Get the full timeline:

Most recent: FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing